Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Richardson LC, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, Mackinnon J.

Am J Public Health. 2006 Jan;96(1):160-6. Epub 2005 Nov 29.

2.

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida.

Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW.

Breast Cancer Res Treat. 2006 Jan;95(1):89-95. Epub 2005 Oct 22.

PMID:
16244785
3.

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.

Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL.

Cancer. 2011 Jan 1;117(1):180-9. doi: 10.1002/cncr.25542. Epub 2010 Oct 11.

4.

Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities.

Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW.

Cancer. 2006 Jan 1;106(1):201-7.

5.

Effects of health insurance and race on early detection of cancer.

Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP.

J Natl Cancer Inst. 1999 Aug 18;91(16):1409-15.

PMID:
10451447
6.

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.

Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY.

Lancet Oncol. 2008 Mar;9(3):222-31. doi: 10.1016/S1470-2045(08)70032-9. Epub 2008 Feb 20.

PMID:
18282806
7.

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J.

J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.

PMID:
22147735
8.

The relation between health insurance coverage and clinical outcomes among women with breast cancer.

Ayanian JZ, Kohler BA, Abe T, Epstein AM.

N Engl J Med. 1993 Jul 29;329(5):326-31.

9.

Insurance status and stage of cancer at diagnosis among women with breast cancer.

Halpern MT, Bian J, Ward EM, Schrag NM, Chen AY.

Cancer. 2007 Jul 15;110(2):403-11.

10.

Treatment variation by insurance status for breast cancer patients.

Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B.

Breast J. 2008 Mar-Apr;14(2):128-34. doi: 10.1111/j.1524-4741.2007.00542.x.

PMID:
18315690
11.

Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005.

Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM.

Med Care. 2008 Jul;46(7):692-700. doi: 10.1097/MLR.0b013e31817893b1.

PMID:
18580388
12.

The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?

Shone LP, Dick AW, Brach C, Kimminau KS, LaClair BJ, Shenkman EA, Col JF, Schaffer VA, Mulvihill F, Szilagyi PG, Klein JD, VanLandeghem K, Bronstein J.

Pediatrics. 2003 Dec;112(6 Pt 2):e521.

PMID:
14654674
13.

Effects of health insurance and race on breast carcinoma treatments and outcomes.

Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP.

Cancer. 2000 Dec 1;89(11):2202-13.

PMID:
11147590
14.

Differential impact of recent Medicaid expansions by race and ethnicity.

Racine AD, Kaestner R, Joyce TJ, Colman GJ.

Pediatrics. 2001 Nov;108(5):1135-42.

PMID:
11694693
15.

The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.

Ward EM, Fedewa SA, Cokkinides V, Virgo K.

Cancer J. 2010 Nov-Dec;16(6):614-21. doi: 10.1097/PPO.0b013e3181ff2aec.

PMID:
21131794
16.

Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.

Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. doi: 10.1158/1055-9965.EPI-12-1225. Epub 2012 Dec 28.

17.

Variations in breast cancer treatment by patient and provider characteristics.

Ayanian JZ, Guadagnoli E.

Breast Cancer Res Treat. 1996;40(1):65-74. Review.

PMID:
8888153
18.

Breast biopsy and race/ethnicity among women without breast cancer.

Jacobson JS, Grann VR, Hershman D, Troxel AB, Li H, Neugut AI.

Cancer Detect Prev. 2006;30(2):129-33. Epub 2006 Apr 18.

PMID:
16621329
19.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
20.

Disparities associated with advanced prostate cancer stage at diagnosis.

Marlow NM, Halpern MT, Pavluck AL, Ward EM, Chen AY.

J Health Care Poor Underserved. 2010 Feb;21(1):112-31. doi: 10.1353/hpu.0.0253.

PMID:
20173259

Supplemental Content

Support Center